An essential part for Rho–associated kinase in the transcellular invasion of tumor cells

[1]  K. Fujisawa,et al.  Role of citron kinase as a target of the small GTPase Rho in cytokinesis , 1998, Nature.

[2]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[3]  R. Treisman,et al.  RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation , 1998, The EMBO journal.

[4]  F. Matsumura,et al.  Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.

[5]  F. Matsumura,et al.  Specific Localization of Serine 19 Phosphorylated Myosin II during Cell Locomotion and Mitosis of Cultured Cells , 1998, The Journal of cell biology.

[6]  M. Stack,et al.  Intact Vitronectin Induces Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinases-2 Expression and Enhanced Cellular Invasion by Melanoma Cells* , 1998, The Journal of Biological Chemistry.

[7]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[8]  K. Fujisawa,et al.  p160ROCK, a Rho‐associated coiled‐coil forming protein kinase, works downstream of Rho and induces focal adhesions , 1997, FEBS letters.

[9]  D. Talbot,et al.  Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer. , 1996, European journal of cancer.

[10]  Yoshiharu Matsuura,et al.  Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.

[11]  S. Narumiya.  The small GTPase Rho: cellular functions and signal transduction. , 1996, Journal of biochemistry.

[12]  K. Burridge,et al.  Rho-stimulated contractility drives the formation of stress fibers and focal adhesions , 1996, The Journal of cell biology.

[13]  T. Yamamoto,et al.  Rho‐associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. , 1996, The EMBO journal.

[14]  K. Fujisawa,et al.  The small GTP‐binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase. , 1996, The EMBO journal.

[15]  L. Lim,et al.  A Novel Serine/Threonine Kinase Binding the Ras-related RhoA GTPase Which Translocates the Kinase to Peripheral Membranes (*) , 1995, The Journal of Biological Chemistry.

[16]  L. Liotta,et al.  Tumor invasion and metastasis: an imbalance of positive and negative regulation. , 1991, Cancer research.

[17]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[18]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[19]  I. Fidler,et al.  Cancer metastasis. , 1991, British medical bulletin.

[20]  S. Narumiya,et al.  Asparagine residue in the rho gene product is the modification site for botulinum ADP-ribosyltransferase. , 1989, The Journal of biological chemistry.

[21]  G. Nicolson,et al.  Adhesive, invasive, and growth properties of selected metastatic variants of a murine large-cell lymphoma. , 1989, Invasion & metastasis.